Tyrosinemia: Difference between revisions
Varun Kumar (talk | contribs) No edit summary |
Irfan Dotani (talk | contribs) No edit summary |
||
| (3 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}}; {{AE}} | |||
{{Pleasehelp}} | |||
{{Infobox_Disease | | {{Infobox_Disease | | ||
Name = Tyrosinemia | | Name = Tyrosinemia | | ||
| Line 15: | Line 21: | ||
MeshID = D020176 | | MeshID = D020176 | | ||
}} | }} | ||
==Overview== | |||
'''Tyrosinemia''' (or "Tyrosinaemia") is an error of [[metabolism]], usually inborn, in which the body cannot effectively break down the [[amino acid]] [[tyrosine]]. Symptoms include liver and kidney disturbances and mental retardation. | '''Tyrosinemia''' (or "Tyrosinaemia") is an error of [[metabolism]], usually inborn, in which the body cannot effectively break down the [[amino acid]] [[tyrosine]]. Symptoms include liver and kidney disturbances and mental retardation. | ||
| Line 23: | Line 28: | ||
[[Charles Scriver]], Beaudet, A.L., Valle, D., Sly, W.S., Vogelstein, B., Childs, B., Kinzler, K.W. (Accessed 2007). [http://www.ommbid.com/OMMBID/the_online_metabolic_and_molecular_bases_of_inherited_disease/b/abstract/part8/ch79 The Online Metabolic and Molecular Bases of Inherited Disease.] Chapter 79. New York: McGraw-Hill.</ref> | [[Charles Scriver]], Beaudet, A.L., Valle, D., Sly, W.S., Vogelstein, B., Childs, B., Kinzler, K.W. (Accessed 2007). [http://www.ommbid.com/OMMBID/the_online_metabolic_and_molecular_bases_of_inherited_disease/b/abstract/part8/ch79 The Online Metabolic and Molecular Bases of Inherited Disease.] Chapter 79. New York: McGraw-Hill.</ref> | ||
== | ==Historical Perspective== | ||
==Classification== | |||
[[Image:autorecessive.svg|thumb|right|Tyrosinemia is inherited in an [[autosomal recessive]] pattern.]] There are three types of tyrosinemia, each with distinctive symptoms and caused by the deficiency of a different enzyme. | [[Image:autorecessive.svg|thumb|right|Tyrosinemia is inherited in an [[autosomal recessive]] pattern.]] There are three types of tyrosinemia, each with distinctive symptoms and caused by the deficiency of a different enzyme. | ||
| Line 29: | Line 36: | ||
* [[Type II tyrosinemia]] | * [[Type II tyrosinemia]] | ||
* [[Type III tyrosinemia]] | * [[Type III tyrosinemia]] | ||
==Pathophysiology== | |||
==Causes== | |||
==Differentiating {{PAGENAME}} from Other Diseases== | |||
==Epidemiology and Demographics== | |||
==Risk Factors== | |||
==Screening== | |||
==Natural History, Complications, and Prognosis== | |||
==Diagnosis== | |||
===Diagnostic Criteria=== | |||
===History and Symptoms=== | |||
===Physical Examination=== | |||
===Laboratory Findings=== | |||
===Imaging Findings=== | |||
===Other Diagnostic Studies=== | |||
==Treatment== | ==Treatment== | ||
Treatment varies depending on the specific type. A [[low protein diet]] may be required in the management of tyrosinemia. Recent experience with [[NTBC]] has shown to be very effective. The most effective treatment in patients with tyrosinemia type I seems to be full or partial liver transplant. | Treatment varies depending on the specific type. A [[low protein diet]] may be required in the management of tyrosinemia. Recent experience with [[NTBC]] has shown to be very effective. The most effective treatment in patients with tyrosinemia type I seems to be full or partial liver transplant. | ||
===Medical Therapy=== | |||
===Surgery=== | |||
===Prevention=== | |||
==See also== | ==See also== | ||
| Line 37: | Line 76: | ||
* [[Ochronosis]] | * [[Ochronosis]] | ||
* [[Inborn error of metabolism]] | * [[Inborn error of metabolism]] | ||
==External links== | ==External links== | ||
* [http://depts.washington.edu/tyros/abouttyr.htm University of Washington] | * [http://depts.washington.edu/tyros/abouttyr.htm University of Washington] | ||
==References== | |||
{{Reflist|2|}} | |||
{{Amino acid metabolic pathology}} | {{Amino acid metabolic pathology}} | ||
[[Category: | [[Category:Hepatology]] | ||
[[Category:Needs patient information]] | [[Category:Needs patient information]] | ||
[[de:Tyrosinämie]] | [[de:Tyrosinämie]] | ||
[[it:Tirosinemia]] | [[it:Tirosinemia]] | ||
Latest revision as of 20:14, 20 July 2016
|
WikiDoc Resources for Tyrosinemia |
|
Articles |
|---|
|
Most recent articles on Tyrosinemia Most cited articles on Tyrosinemia |
|
Media |
|
Powerpoint slides on Tyrosinemia |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Tyrosinemia at Clinical Trials.gov Clinical Trials on Tyrosinemia at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Tyrosinemia
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Tyrosinemia Discussion groups on Tyrosinemia Patient Handouts on Tyrosinemia Directions to Hospitals Treating Tyrosinemia Risk calculators and risk factors for Tyrosinemia
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Tyrosinemia |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
| Tyrosinemia | |
 | |
|---|---|
| Tyrosine | |
| ICD-10 | E70.2 |
| ICD-9 | 270.2 |
| OMIM | 276700 276600 276710 |
| DiseasesDB | 13478 Template:DiseasesDB2 Template:DiseasesDB2 |
| eMedicine | ped/2339 |
| MeSH | D020176 |
Overview
Tyrosinemia (or "Tyrosinaemia") is an error of metabolism, usually inborn, in which the body cannot effectively break down the amino acid tyrosine. Symptoms include liver and kidney disturbances and mental retardation.
Most inborn forms of tyrosinemia produce hypertyrosinemia (high levels of tyrosine).[1]
Historical Perspective
Classification
File:Autorecessive.svg There are three types of tyrosinemia, each with distinctive symptoms and caused by the deficiency of a different enzyme.
Pathophysiology
Causes
Differentiating Tyrosinemia from Other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications, and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Imaging Findings
Other Diagnostic Studies
Treatment
Treatment varies depending on the specific type. A low protein diet may be required in the management of tyrosinemia. Recent experience with NTBC has shown to be very effective. The most effective treatment in patients with tyrosinemia type I seems to be full or partial liver transplant.
Medical Therapy
Surgery
Prevention
See also
External links
References
- ↑ Charles Scriver, Beaudet, A.L., Valle, D., Sly, W.S., Vogelstein, B., Childs, B., Kinzler, K.W. (Accessed 2007). The Online Metabolic and Molecular Bases of Inherited Disease. Chapter 79. New York: McGraw-Hill.